Day: December 9, 2020

TORONTO, Dec. 09, 2020 (GLOBE NEWSWIRE) — Ayr Strategies Inc. (CSE: AYR.A, OTCQX: AYRWF) (“Ayr” or the “Company”), a leading vertically integrated cannabis multi-state operator, is pleased to announce that, due to strong demand, it has increased the size of its previously announced offering of 12.5% Senior Secured Notes (the “Notes”), from US$75 million to US$110 million. Additionally, it has completed an oversubscribed incentive cash exercise of three million of the Company’s share purchase warrants, resulting in gross proceeds to the Company of over US$25 million. In aggregate this week, following closing of the debt offering, the Company will have raised gross proceeds of over $135 million.“This is an unprecedented time for Ayr. We are in the excellent position of being one of the few MSOs for whom capital is readily available,...

HOUSTON, Dec. 09, 2020 (GLOBE NEWSWIRE) — Kayne Anderson NextGen Energy & Infrastructure, Inc. (the “Fund”) (NYSE: KMF) announced today a quarterly distribution of $0.09 per share for the fiscal quarter ended November 30, 2020. This distribution is payable to common stockholders on December 31, 2020 (as outlined in the table below).The Fund expects the next distribution to be declared and paid in March 2021. Payment of future distributions is subject to the Board of Directors’ approval, as well as meeting the covenants of the Fund’s debt agreements and terms of its preferred stock.(1)The return of capital estimate is based on the Fund’s anticipated earnings and profits. The final determination of the tax character of distributions may differ substantially from this preliminary information.Kayne Anderson NextGen Energy &...

HOUSTON, Dec. 09, 2020 (GLOBE NEWSWIRE) — Kayne Anderson Energy Infrastructure Fund, Inc. (the “Company”) (NYSE: KYN) announced today a quarterly distribution of $0.15 per share for the fiscal quarter ended November 30, 2020. This distribution is payable to common stockholders on December 31, 2020 (as outlined in the table below).The Company expects the next distribution to be declared and paid in March 2021. Payment of future distributions is subject to the Board of Directors’ approval, as well as meeting the covenants of the Company’s debt agreements and terms of its preferred stock.(1) The return of capital estimate is based on the Company’santicipatedearnings and profits.The final determination of the tax character of distributions may differ substantially from this preliminary information.Kayne Anderson Energy Infrastructure...

CAESAREA, Israel, Dec. 09, 2020 (GLOBE NEWSWIRE) — Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused on the integration of sleep apnea management into the cardiac patient care pathway, today commented on the recent release of the 2021 Physician Fee Schedule from the U.S. Centers for Medicare & Medicaid Services (CMS). This Fee Schedule represents the third year of a four-year proposed plan to reevaluate reimbursement in home sleep apnea diagnostic codes. The final changes will become effective on January 1, 2021.The 2021 Fee Schedule further widens the gap between the CPT-95800 used with Itamar Medical’s WatchPATTM device of approximately $163, a -3.5% decrease from 2020, compared to CPT-code 95806 used with competitive Home Sleep Apnea Testing (HSAT) devices of approximately...

Not for distribution to United States newswire services or for dissemination in the United StatesOTTAWA, Dec. 09, 2020 (GLOBE NEWSWIRE) — Cornerstone Capital Resources Inc. (“Cornerstone” or “the Company”) (TSXV:CGP) (Frankfurt:GWN) (Berlin:GWN) (OTC:CTNXF) announces completion of its non-brokered private placement (the “Offering”), the proposed terms of which were previously announced on November 24 and November 25, 2020.The Offering consisted of the issuance of 1,540,000 common shares at an issue price of $5.00 per common share for total gross proceeds of $7,700,000. The Company intends to use the proceeds of the Offering for working capital and general corporate purposes.The Offering includes participation by insiders of Cornerstone totalling 380,000 common shares, which constitutes a “related party transaction” as defined in...

SAN DIEGO, Dec. 09, 2020 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced that it has entered into an underwriting agreement with H.C. Wainwright & Co., LLC under which the underwriter has agreed to purchase on a firm commitment basis 8,888,889 shares of common stock of the Company, at a price to the public of $4.50 per share, less underwriting discounts and commissions. The closing of the offering is expected to occur on or about December 14, 2020, subject to satisfaction of customary closing conditions.H.C. Wainwright & Co. is acting as the sole book-running manager for the offering.The Company also has granted to the underwriter a 30-day option to purchase up to an additional 1,333,333 shares...

VANCOUVER, British Columbia, Dec. 09, 2020 (GLOBE NEWSWIRE) — Imperial Metals Corporation (the “Company”) (TSX:III) reports on the exploration program focused on the discovery of additional zones of higher grade mineralization within the Red Chris porphyry corridor.Eight drill holes totaling 12,652 metres have been completed since September. All drill holes intersected mineralization, except two that were dedicated geotechnical holes. A total of 99,018 metres of drilling from 77 drill holes has been completed since August 2019.At the East Zone, drilling has confirmed the potential for additional high grade mineralization south of the South Boundary Fault. This is a significant discovery that has the potential to expand the known area of the Red Chris Porphyry system as the South Boundary Fault has historically been assumed to define...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATESTORONTO, Dec. 09, 2020 (GLOBE NEWSWIRE) — RioCan Real Estate Investment Trust (“RioCan” or the “Trust”) (TSX: REI.UN) today announced that it is issuing a notice of redemption to holders of its $250 million, 3.716% Series R senior unsecured debentures due December 13, 2021 (the “Debentures”). The Debentures will be redeemed in full on January 15, 2021 (the “Redemption Date”) in accordance with their terms.Pursuant to the terms of the trust indenture governing the Debentures, the Debentures will be redeemed at a redemption price equal to the greater of the “Canada Yield Price” and par, together in each case with accrued and unpaid interest to the Redemption Date. The “Canada Yield Price” calculated in accordance of the terms of the governing trust indenture,...

New randomised, double-blind, placebo-controlled phase II clinical study to commence in Q1 CY2021Evaluates the efficacy and safety of eftilagimod alpha in combination with paclitaxel chemotherapy, compared to placebo plus paclitaxel (as per AIPAC study)Fully funded by EOC Pharma, trial will involve approx. 152 patients across 20 clinical trial sites in ChinaFollows encouraging data from Immutep’s ongoing AIPAC Phase IIb study announced end of March and today and presented at the San Antonio Breast Cancer SymposiumGlobal webinar: 11 December at 8.30 am Australian Easter Daylight Time, details belowSydney, AUSTRALIA, Dec. 10, 2020 (GLOBE NEWSWIRE) —  Immutep Limited (ASX: IMM; NASDAQ: IMMP) a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune diseases, is pleased to announce that its Chinese...